Lyfegen

Basel, Switzerland Founded: 2018 • Age: 8 yrs
Provider of pricing model databases for drugs and medical devices

About Lyfegen

Lyfegen is a Technology company based in Basel (Switzerland) founded in 2018. Provider of pricing model databases for drugs and medical devices. Lyfegen has raised $16.64 million across 4 funding rounds from investors including TX Ventures, aMoon and APEX Ventures. Lyfegen offers products and services including Lyfegen Platform. Its focus areas include Enterprise Applications, Data as a Service, Industries and Healthcare Data.

Company details

Lyfegen was founded in 2018 in Basel, Switzerland, within the healthcare sector. Databases containing pricing models for drugs and medical devices are maintained, enabling payers to monitor patient treatments and allocate funds. Access to public agreements, contracts, and drug pricing information is offered to regulators, pharmaceutical companies, and payers. Real-time tracking of financial performance is also facilitated through the platform.

  • Headquarters Basel, Switzerland
  • Sectors
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website lyfegen.com
  • Social LinkedIn X
Operational Areas
Key Metrics
  • Total Equity Funding
    $16.64M (USD)

    in 4 rounds

  • Latest Funding Round
    $5.68M (USD), Series A

    Dec 2024

  • Investors

Products & Services of Lyfegen

Lyfegen offers a comprehensive portfolio of products and services, including Lyfegen Platform.

Lyfegen Platform
Pharma Access Platform

Platform for exploring and connecting pharma payers and providers.

Funding Insights of Lyfegen

Lyfegen has successfully raised a total of $16.64M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $5.68 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $16.64M
  • Total Rounds 4
  • Last Round Series A β€” $5.68M
  • First Round $745,625

    (Apr 2019)

  • Investors Count 3

All 4 funding rounds of Lyfegen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2024$5.68MSeries A–TX Ventures
Sep 2022$8MSeries A–aMoon
Sep 2020$2.21MSeries A––
–
Apr 2019$745,625Seed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Lyfegen

Lyfegen has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include TX Ventures, aMoon and APEX Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are made in Fintech and related sectors by TX Ventures.
tx.venturesZurich, Switzerland
Venture capital investments in healthcare are focused on by aMoon.
amoon.fund
Venture capital funding is offered for deep-tech and medical startups.
apex.venturesVienna, Austria
Premium access

Investor details for Lyfegen

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Lyfegen

3 dated milestones of Lyfegen across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lyfegen is founded.
  2. Funding First funding round of $746K.
  3. Funding Latest funding round, Series A, of $5.7M.

Web traffic of Lyfegen

The website of Lyfegen (lyfegen.com) receives about 2.9K visits a month.

  • Monthly visits
    2.9K

    ▲ 108.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lyfegen

Premium access

Complete news archive for Lyfegen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lyfegen

Lyfegen was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Lyfegen is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.

Lyfegen is a funded company, having raised a total of $16.64M across 4 funding rounds to date. The company's 1st funding round was a Seed of $745.63K, raised on Apr 2019.

Lyfegen was founded in 2018 in Basel, Switzerland, within the healthcare sector. Databases containing pricing models for drugs and medical devices are maintained, enabling payers to monitor patient treatments and allocate funds. Access to public agreements, contracts, and drug pricing information is offered to regulators, pharmaceutical companies, and payers. Real-time tracking of financial performance is also facilitated through the platform.

Lyfegen offers Lyfegen Platform.

Lyfegen has 3 investors. Key investors include TX Ventures, aMoon, and APEX Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available